Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the closure of the trading window pursuant to SEBI regulations related to insider trading. It specifies the trading window closure period around the release of quarterly financial results but does not contain any financial data, results, or detailed report. The document is short (1147 characters) and serves as an announcement or regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-30 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure of related party transactions for the half year ended 31 March 2022, submitted to stock exchanges in compliance with SEBI regulations. It contains specific financial data on transactions between the company and its related parties, including subsidiaries, joint ventures, and key managerial personnel. The document is not a full financial report like an Annual Report or Interim Report, but a regulatory disclosure focused on related party transactions. It is not a brief announcement or a certification letter, but a substantive disclosure with financial figures. Such disclosures typically fall under Regulatory Filings (RNS) as they are compliance documents required by stock exchanges and regulators, and do not constitute standalone financial reports like 10-K or IR. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-06-03 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held by Hester Biosciences Limited on May 20, 2022, discussing the financial results for the quarter and year ended March 31, 2022. It includes detailed management commentary on financial performance, business segments, market conditions, and future outlook, followed by a Q&A session. The presence of a full transcript of the call, including management discussion and Q&A, clearly identifies this as a Call Transcript (CT). The document length (15,000 characters) and content confirm it is not a brief announcement or summary but a full transcript. Therefore, the appropriate classification is CT with high confidence.
2022-05-26 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a compliance notice under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the loss of share certificates by a shareholder. It is a regulatory announcement related to share certificate status and trading caution, not a financial report, meeting material, or management information. The document is short (1328 characters) and serves as a formal notification to exchanges, fitting the description of a Regulatory Filing (RNS).
2022-05-23 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges submitting newspaper clippings of the extract of consolidated audited financial results for the quarter and year ended 31 March 2022. It references compliance with SEBI Listing Regulations and provides published extracts of financial results, but does not contain the full financial report itself. The document length is short (1590 characters) and it states that the financial results have been published in newspapers, indicating this is an announcement or notification rather than the full report. Therefore, this fits the category of Regulatory Filings (RNS) as a general regulatory announcement and disclosure rather than the full Annual Report (10-K) or Interim Report (IR).
2022-05-21 English
Press Release
Annual Report Classification · 100% confidence The document is dated 20 May 2022 and is addressed to stock exchanges, indicating a formal regulatory disclosure. It reports the outcome of a Board Meeting where the Board approved the audited standalone and consolidated financial results for the quarter and year ended 31 March 2022. It includes detailed financial highlights, profitability analysis, and operational updates for FY22. The document also mentions the audit report with an unmodified opinion by the statutory auditors. The presence of detailed financial data, including revenues, profits, margins, and EPS, confirms this is a full financial report rather than a brief announcement or certification. The document also includes a press release with comprehensive financial results and business updates. Therefore, this document is the official Annual Report covering the full fiscal year 2021-22 financial performance and activities of the company, consistent with the definition of an Annual Report (10-K).
2022-05-20 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.